Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

IMAB – I-Mab ADR

Name : I-MAB
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.00000000000000
EPSttm :
finviz dynamic chart for IMAB

Float Short %

5.74

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.03

EPS Last/This Y

-0.04

EPS This/Next Y

-0.01

Price

4.64

Target Price

8.33

Analyst Recom

1

Performance Q

130.35

Relative Volume

0.31

Beta

1.47

Ticker: IMAB



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-13IMAB4.63N/AN/A0
2025-11-14IMAB4.63N/AN/A0
2025-11-17IMAB4.63N/AN/A0
2025-11-18IMAB4.63N/AN/A0
2025-11-19IMAB4.63N/AN/A0
2025-11-20IMAB4.63N/AN/A0
2025-11-21IMAB4.63N/AN/A0
2025-11-24IMAB4.63N/AN/A0
2025-11-25IMAB4.63N/AN/A0
2025-11-26IMAB4.63N/AN/A0
2025-12-01IMAB4.63N/AN/A0
2025-12-02IMAB4.63N/AN/A0
2025-12-03IMAB4.63N/AN/A0
2025-12-04IMAB4.63N/AN/A0
2025-12-05IMAB4.63N/AN/A0
2025-12-08IMAB4.63N/AN/A0
2025-12-09IMAB4.63N/AN/A0
2025-12-10IMAB4.63N/AN/A0
2025-12-11IMAB4.63N/AN/A0
2025-12-12IMAB4.63N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



No data found



No data found

[stock_market_widget type="chart" template="candlestick" assets="IMAB" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS​

-0.07

Avg. EPS Est. Current Quarter

-0.05

Avg. EPS Est. Next Quarter

-0.04

Insider Transactions

Institutional Transactions

3.21

Beta

1.47

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

10

Growth Score

18

Sentiment Score

76

Actual DrawDown %

94.6

Max Drawdown 5-Year %

-99.3

Target Price

8.33

P/E

Forward P/E

PEG

P/S

P/B

1.92

P/Free Cash Flow

EPS

-0.71

Average EPS Est. Cur. Y​

-0.31

EPS Next Y. (Est.)

-0.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.31

Return on Equity vs Sector %

-44.8

Return on Equity vs Industry %

-31.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”IMAB” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”IMAB” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”IMAB” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”IMAB” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”IMAB” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”IMAB” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”IMAB” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
I-MAB
Sector: Healthcare
Industry: Biotechnology
Employees: 32
I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. I-Mab was founded in 2014 and is headquartered in Rockville, Maryland.
stock quote shares IMAB – I-Mab ADR Stock Price stock today
news today IMAB – I-Mab ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch IMAB – I-Mab ADR yahoo finance google finance
stock history IMAB – I-Mab ADR invest stock market
stock prices IMAB premarket after hours
ticker IMAB fair value insiders trading